Proscia: Rewiring cancer diagnosis through digitization and AI to improve patient outcomes Philadelphia – November 20, 2024 – Proscia®, a global leader in AI-enabled pathology solutions for precision medicine, was named to Fast...

NEW YORK--(BUSINESS WIRE)--Paige, a leader in next-generation AI technology, announces the launch of OmniScreen, a pioneering AI-driven biomarker module capable of evaluating over 505 genes and detecting 1,228 molecular biomarkers from...

PathAI remains an independent company, focused on developing innovative AI and digital pathology solutions SECAUCUS, N.J. and BOSTON, June 11, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information...

PathAI: Transaction is part of wide-ranging collaboration to combine Quest's oncology expertise and scale with PathAI's AI and digital pathology innovations to speed diagnosis, improve quality and reduce costs  SECAUCUS, N.J. and BOSTON –...

Cancer mortality in the U.S. has fallen over the past three decades, but increases in common forms of the disease pose a threat to that progress. The number of new cancer cases in the U.S. is expected to top 2 million for the first time in...

Gestalt: Revolutionizing their Pathology Services, Sagis Adopts Digital Pathology and AI  SPOKANE, Wash., Jan. 11, 2024 /PRNewswire/ -- Gestalt announces the addition of Sagis Diagnostics to their customer roster. Recognizing the evolving...